Infections caused by carbapenem-resistant Acinetobacter baumannii (CRAB) have limited therapeutic options. Sulbactam-durlobactam is a combination of two beta lactamase inhibitors with activity against CRAB under phase 3 clinical investigation. We performed a systematic review on in vitro studies reporting A. baumannii resistances against sulbactam/durlobactam. We considered "resistant" species to be those with MIC >= 8 mg/L. Ten studies were included in the review (9754 tested isolates). Overall, 2.3% of A. baumannii were resistant to sulbactam/durlobactam, and this percentage rose to 3.4% among CRAB subgroups and to 3.7% among colistin-resistant strains. Resistance was 100% among metallo beta-lactamase-producing strains. Overall, in 12.5% of cases, sulbactam/durlobactam resistance was associated with the production of NDM-1, in 31.7% of cases with the substitutions in the PBP3 determinants, and in the remaining cases the resistance mechanism was unknown. In conclusion, A. baumannii resistance towards sulbactam/durlobactam is limited, except for MBL-producing strains.

Acinetobacter baumannii Resistance to Sulbactam/Durlobactam: A Systematic Review / Principe, Luigi; Di Bella, Stefano; Conti, Jacopo; Perilli, Mariagrazia; Piccirilli, Alessandra; Mussini, Cristina; Decorti, Giuliana. - In: ANTIBIOTICS. - ISSN 2079-6382. - 11:12(2022), pp. 1793-1802. [10.3390/antibiotics11121793]

Acinetobacter baumannii Resistance to Sulbactam/Durlobactam: A Systematic Review

Conti, Jacopo;Mussini, Cristina;
2022

Abstract

Infections caused by carbapenem-resistant Acinetobacter baumannii (CRAB) have limited therapeutic options. Sulbactam-durlobactam is a combination of two beta lactamase inhibitors with activity against CRAB under phase 3 clinical investigation. We performed a systematic review on in vitro studies reporting A. baumannii resistances against sulbactam/durlobactam. We considered "resistant" species to be those with MIC >= 8 mg/L. Ten studies were included in the review (9754 tested isolates). Overall, 2.3% of A. baumannii were resistant to sulbactam/durlobactam, and this percentage rose to 3.4% among CRAB subgroups and to 3.7% among colistin-resistant strains. Resistance was 100% among metallo beta-lactamase-producing strains. Overall, in 12.5% of cases, sulbactam/durlobactam resistance was associated with the production of NDM-1, in 31.7% of cases with the substitutions in the PBP3 determinants, and in the remaining cases the resistance mechanism was unknown. In conclusion, A. baumannii resistance towards sulbactam/durlobactam is limited, except for MBL-producing strains.
2022
11
12
1793
1802
Acinetobacter baumannii Resistance to Sulbactam/Durlobactam: A Systematic Review / Principe, Luigi; Di Bella, Stefano; Conti, Jacopo; Perilli, Mariagrazia; Piccirilli, Alessandra; Mussini, Cristina; Decorti, Giuliana. - In: ANTIBIOTICS. - ISSN 2079-6382. - 11:12(2022), pp. 1793-1802. [10.3390/antibiotics11121793]
Principe, Luigi; Di Bella, Stefano; Conti, Jacopo; Perilli, Mariagrazia; Piccirilli, Alessandra; Mussini, Cristina; Decorti, Giuliana
File in questo prodotto:
File Dimensione Formato  
antibiotics-11-01793.pdf

Open access

Tipologia: Versione pubblicata dall'editore
Dimensione 570.11 kB
Formato Adobe PDF
570.11 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/1296649
Citazioni
  • ???jsp.display-item.citation.pmc??? 9
  • Scopus 19
  • ???jsp.display-item.citation.isi??? 17
social impact